HSV-1/2 gB Antibody (H1359) is a mouse monoclonal IgG1 antibody that detects glycoprotein B (gB) of HSV-1 and HSV-2 by western blotting (WB) and immunofluorescence (IF). Anti-HSV-1/2 gB antibody (H1359) is essential for studying the role of gB in the viral life cycle, as glycoprotein B is a critical component of the herpes simplex virus envelope that facilitates membrane fusion, a key step in viral entry into host cells. The gB protein exists as a homodimer, which is crucial for its function, and is linked by disulfide bonds, ensuring stability and proper interaction with other viral glycoproteins during the fusion process. The extracellular domain of HSV-1 gB spans amino acids 31 to 730, while the cytoplasmic domain extends from amino acids 796 to 904, and similar structural features are observed in HSV-2 gB. Understanding the structure of gB is vital, as gB not only plays a role in viral entry but also serves as a target for therapeutic interventions and vaccine development. HSV-1/2 gB (H1359) monoclonal antibody is an invaluable tool for researchers investigating the mechanisms of herpes simplex virus infection and the development of antiviral strategies.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
HSV-1/2 gB Antibody (H1359) References:
- Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro. | Wachsman, MB., et al. 2003. Antiviral Res. 58: 17-24. PMID: 12719003
- Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. | Lyu, SY., et al. 2005. Arch Pharm Res. 28: 1293-301. PMID: 16350858
- Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide. | Luo, C., et al. 2007. Virus Genes. 34: 263-72. PMID: 16927131
- Identification of an HSV-1/HSV-2 cross-reactive T cell determinant. | Grammer, SF., et al. 1990. J Immunol. 145: 2249-53. PMID: 1697879
- Single dose of glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses. | Iyer, AV., et al. 2013. Virol J. 10: 317. PMID: 24165088
- Auto-associative heparin nanoassemblies: a biomimetic platform against the heparan sulfate-dependent viruses HSV-1, HSV-2, HPV-16 and RSV. | Lembo, D., et al. 2014. Eur J Pharm Biopharm. 88: 275-82. PMID: 24835150
- Functional comparison of herpes simplex virus 1 (HSV-1) and HSV-2 ICP27 homologs reveals a role for ICP27 in virion release. | Park, D., et al. 2015. J Virol. 89: 2892-905. PMID: 25540385
- Characterization of a Herpes Simplex Virus 1 (HSV-1) Chimera in Which the Us3 Protein Kinase Gene Is Replaced with the HSV-2 Us3 Gene. | Shindo, K., et al. 2016. J Virol. 90: 457-73. PMID: 26491159
- Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones. | Bonneau, RH., et al. 1993. Virology. 195: 62-70. PMID: 7686314
- The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2. | Peng, T., et al. 1996. Virology. 216: 184-96. PMID: 8614985